SAGE

Sage Therapeutics (SAGE)

About Sage Therapeutics (SAGE)

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Details

Daily high

$8.56

Daily low

$7.99

Price at open

$8.05

52 Week High

$19.34

52 Week Low

$4.62

Market cap

524.4M

Dividend yield

0.00%

Volume

1.8M

Avg. volume

1.2M

P/E ratio

-1.29

Sage Therapeutics News